Humasis
Humasis Co., Ltd. specializes in studying the rapid test kit with its differentiated technology. Humasis is making every effort to secure various source technologies in order to respond to the rapidly changing in vitro diagnostic reagent development technology. Humasis’s IVD(InVitro Diagnostics) R&D Team is studying and developing various types of diagnostic kits to discover diagnostic markers related to diseases that can threaten human health and happiness and analyze them by the immunochromatographic method. In particular, we are actively conducting research on viral infectious diseases with high mortality and infectivity, such as new coronavirus, influenza virus, and dengue virus.
Humasis COVID-19 Ag Home Test – 1 Test
- Can be used as Nasopharyngeal swab or as Nasal Swab test
- High sensitivity and specificity at the early stage of infection
- Result within 15 minutes
- Detects COVID-19 virus variants (Alpha, Beta, Gamma, Delta, Omicron, etc.)
- Approved by international quality testing agencies such as US FDA, UK MHRA, BfArM, Paul-Ehrlich-Institut, ANVISA, KFDA, and Thai FDA
- Thai FDA approval No. T 6400484

Humasis COVID-19 Ag Home Test – 5 Tests
- Can be used as Nasopharyngeal swab or as Nasal Swab test
- High sensitivity and specificity at the early stage of infection
- Result within 15 minutes
- Detects COVID-19 virus variants (Alpha, Beta, Gamma, Delta, Omicron, etc.)
- Approved by international quality testing agencies such as US FDA, UK MHRA, BfArM, Paul-Ehrlich-Institut, ANVISA, KFDA, and Thai FDA
- Thai FDA approval No. T 6400145

Humasis COVID-19 Ag Test – 25 Test
- Nasopharyngeal swab or as Nasal Swab test
- High sensitivity and specificity at the early stage of infection
- Clinical sensitivity of 98.4% and Clinical specificity 100%
- Result within 15 minutes
- Detects COVID-19 virus variants (Alpha, Beta, Gamma, Delta, Omicron, etc.)
- Approved by international quality testing agencies such as US FDA, UK MHRA, BfArM, Paul-Ehrlich-Institut, ANVISA, KFDA, and Thai FDA
- Thai FDA approval No. T 6400042 (for Professional use), T 6400484 (for Home/Self use)
- For patients suspected of current COVID-19 infection
- Highly growing infection rate places
- Site or environment limited in using Rt-PCR test
